Combining genetic and proteomic data from Alzheimer's disease patients, a team led by researchers from Emory University has uncovered new details about how the degenerative brain condition develops. As reported in Nature Genetics, the scientists integrated Alzheimer's disease genome-wide association study results with human brain proteomes to identify genes that confer disease risk via their effects on brain protein abundance.